Delving into the Latest Updates on Octapharma Gmbh with Synapse

Non-interventional study to capture data on the use of a VWF/FVIII concentrate (wilate®) in all clinical settings of von Willebrand disease including health-related quality of life

开始日期2020-06-01

申办/合作机构

Octapharma Gmbh

CTR20171633 / Completed临床3期

评价人源重组第8因子在中国重度甲型血友病患者中的临床疗效、免疫原性、药代动力学和安全性的前瞻性临床研究

评估Human-cl rhFVIII预防和治疗出血事件（BE）的临床效果。确定的药代动力学特征，测定增量体内回收率-在研究开始时和随着时间的推移，研究潜在免疫原性，评估Human-cl rhFVIII作为手术预防药物的效果，评估安全性。

开始日期2018-06-29

申办/合作机构

精鼎医药研究开发（上海）有限公司

[+2]

ISRCTN57549638 / RecruitingN/A

Prevention of bleeding in haemophilia A by prophylactic treatment with Octanate®, Wilate®, Nuwiq®: a prospective, multi-national, non-interventional study to evaluate routine practice prophylactic treatment schedules – NIS-Previq

开始日期2015-03-01

申办/合作机构

Octapharma Gmbh

100 项与 Octapharma Gmbh 相关的临床结果

登录后查看更多信息

0 项与 Octapharma Gmbh 相关的专利（医药）

登录后查看更多信息

10

项与 Octapharma Gmbh 相关的文献（医药）

2023-02-01·GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark

A snapshot analysis of a prospective, non-interventional study to evaluate real-life prophylactic treatment schedules of factor VIII concentrates

作者: Oldenburg, J ; Wenning, S ; Seeger, S ; Feddern, J ; Halimeh, S ; Behnisch, W ; Klamroth, R ; Escuriola, C

2019-02-01·Science meets clinical practice

Haemophilia A Prophylaxis with FVIII in Real-life: Snapshot Analysis on the Observational Study “Prevention of Bleeding in Haemophilia A by Prophylactic Treatment with Octanate®, Wilate® or Nuwiq® - NIS Previq”

作者: Klamroth, R. ; Seeger, S. ; Wenning, S. ; Feddern, J. ; Scholz, U. ; Huth-Kühne, A. ; Escuriola-Ettingshausen, C. ; Oldenburg, J. ; Halimeh, S.

2019-02-01·Science meets clinical practice

Interim Results of a Non-interventional Study on Efficacy and Tolerability of a VWF/FVIII Concentrate in von Willebrand's Disease

作者: Kadar, J. ; Alesci, S. ; Lang, T. ; Rieke, M. ; Halimeh, S. ; Seeger, S. ; Koscielny, J. ; Feddern, J. ; von Depka, M. ; Daoud, M. ; Dempfle, C.-E.

100 项与 Octapharma Gmbh 相关的药物交易

登录后查看更多信息

100 项与 Octapharma Gmbh 相关的转化医学

登录后查看更多信息